Organised by the FIP Industrial Pharmacy Section, with special thanks to Glasgow City of Science and Innovation and the Glasgow Science Centre
Separate registration required
Choosing the right career path is usually not a done deal; as a pharmacist/scientist you have a wealth of choice out there. This one-day event could open up new and unimagined avenues, introduce different roles and specialisation possibilities in pharmaceutical industry, and increase your knowledge of pharmaceutical industry and drug development in general.
Industrial Insights is directed at pharmacists or pharmaceutical scientists in the early stages of their career or interested in changing sector.
The event will aim at introducing different roles and specialisation possibilities in the pharmaceutical industry and increase the knowledge of pharmaceutical industry and drug development in general.
09.00 | Registration and coffee & pastries |
09.30 | Welcome and Introduction
Mike Anisfeld, President of Industrial Pharmacy Section (confirmed) Linda Hakes, Immediate Past Chairman, Academy of Pharmaceutical Sciences (confirmed)
|
9.40 | Keynote address – Innovation in Glasgow
Susie Mitchell (confirmed) Programme Director Glasgow City of Science and Innovation |
10.15 | From discovery to medicine – A Day in the life – Panel I
MODERATOR: Linda Hakes, IPS immediate past president, Vice President of FIP and member of Board for Pharmaceutical Sciences
PRESENTER 1: Research & Development; Hannah Batchelor, Biopharmaceutics Scientist, University of Birmingham (confirmed) PRESENTER 2: Drug Delivery; Janet Halliday, Associate Vice President, FCT and External Technology, Ferring Pharmaceuticals (confirmed) PRESENTER 3: Pharmaceutical Development; Bridgette McGeever, Formulation Scientist, Ferring Pharmaceuticals Ferring (confirmed) PRESENTER 4: Quality Management; Forum Jalundhwala, Quality Compliance Manager, Shreenath Chemicals (confirmed)
|
11.30 | Short leg stretching break |
11.45
|
Molecules to Medicines interactive game: Live out the process of making a medicine, the decisions, risks and costs. Can your team get your medicine approved?
Led by Claire Thompson and Hannah Batchelor on behalf of APS (confirmed)
|
13.15
|
Lunch + networking
|
14.15 | From the medicine to the patient – A Day in the life – Panel II
Moderator: Hannah Batchelor, APS
PRESENTER 1: Medical Affairs; Kerstin Neumann, Medical Affairs Manager, Johnson & Johnson (confirmed) PRESENTER 2: Sales and Marketing; Sola Solarin, Managing Partner, Savante consulting (confirmed) PRESENTER 3: Regulatory Affairs; Alan Chalmers, Owner/Director, Pharma International (confirmed) PRESENTER 4: Policy&Intelligence, Advocacy; Sini Eskola, Director Regulatory, Drug Development and Manufacturing, EFPIA (confirmed)
|
15.30 | Short leg stretching + coffee break
|
15.45 | Pharmaceutical Care in Digital Revolution – Focus on the role of a pharmacist and industry
Claudia Rijcken, PhD PharmD MHA, RE Director Digital Innovation Novartis & Founder pharmacare.ai (confirmed)
|
16.15 | Interactive plenary session – Impact of technology on industry and the role of a pharmacist
Moderator: Claire Thompson, Deputy Chief Scientist, Royal Pharmaceutical Society UK
Panelists: Claudia Rijcken (see above) Anna Laven, German Society for Interprofessional Collaboration in Healthcare, Founding member and chairperson of the board, Berlin, Germany & Pharmabrain, Owner and Managing Director (confirmed) Sarah Sinclair, Executive Officer at Australian Government Department of Human Services (confirmed) Christian Roth, President of International Pharmaceutical Students’ Federation (IPSF) 2017-2018 (confirmed) Kerstin Neumann, Medical Affairs Manager, Johnson&Johnson (confirmed)
|
16.55 | Closing remarks
Sini Eskola, Executive Member of IPS, EFPIA
|
17.00 | END |